Zdrowie i gospodarka · 04/10/1996

Advisory Committee Meeting; Amendment of Notice

The Food and Drug Administration (FDA) is announcing an amendment to the notice of a joint meeting of the Nonprescription Drugs Advisory Committee and the Pulmonary-Allergy Drugs Advisory Committee, which is scheduled for October 10 and 11, 1996. This meeting was announced in the Federal Register of September 24, 1996 (61 FR 50031 at 50032). The amendment is being made to announce the cancellation of the entire session on October 11, 1996. There are no other changes. This amendment will be announced at the beginning of the open portion of the meeting.